Episode 120
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150
Published on 6 months, 4 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate